To prevent diseases from occurring in the first place, it is important to identify those individuals who are at particularly high risk as early as possible. Yet current screening methods are often costly and focus only on one disease at a time. Scientists from the Berlin Institute of Health ... more
AI-based analysis system for the diagnosis of breast cancer
For the first time, morphological, molecular and histological data are integrated in a single analysis
Researchers at TU Berlin and Charité – Universitätsmedizin Berlin as well as the University of Oslo have developed a new tissue-section analysis system for diagnosing breast cancer based on artificial intelligence (AI). Two further developments make this system unique: For the first time, morphological, molecular and histological data are integrated in a single analysis. Secondly, the system provides a clarification of the AI decision process in the form of heatmaps. Pixel by pixel, these heatmaps show which visual information influenced the AI decision process and to what extent, thus enabling doctors to understand and assess the plausibility of the results of the AI analysis. This represents a decisive and essential step forward for the future regular use of AI systems in hospitals.
Cancer treatment is increasingly concerned with the molecular characterization of tumor tissue samples. Studies are conducted to determine whether and/or how the DNA has changed in the tumor tissue as well as the gene and protein expression in the tissue sample. At the same time, researchers are becoming increasingly aware that cancer progression is closely related to intercellular cross-talk and the interaction of neoplastic cells with the surrounding tissue - including the immune system.
Image data provide high spatial detail
Although microscopic techniques enable biological processes to be studied with high spatial detail, they only permit a limited measurement of molecular markers. These are rather determined using proteins or DNA taken from tissue. As a result, spatial detail is not possible and the relationship between these markers and the microscopic structures is typically unclear. “We know that in the case of breast cancer, the number of immigrated immune cells, known as lymphocytes, in tumor tissue has an influence on the patient’s prognosis. There are also discussions as to whether this number has a predictive value - in other words if it enables us to say how effective a particular therapy is,” says Professor Dr. Frederick Klauschen from the Institute of Pathology at the Charité.
“The problem we have is the following: We have good and reliable molecular data and we have good histological data with high spatial detail. What we don’t have as yet is the decisive link between imaging data and high-dimensional molecular data,” adds Professor Dr. Klaus-Robert Müller, professor of machine learning at TU Berlin. Both researchers have been working together for a number of years now at the national AI center of excellence the Berlin Institute for the Foundations of Learning and Data (BIFOLD) located at TU Berlin.
Missing link between molecular and histological data
It is precisely this symbiosis which the newly published approach makes possible. “Our system facilitates the detection of pathological alterations in microscopic images. Parallel to this, we are able to provide precise heatmap visualizations showing which pixel in the microscopic image contributed to the diagnostic algorithm and to what extent,” explains Müller. The research team has also succeeded in significantly further developing this process: “Our analysis system has been trained using machine learning processes so that it can also predict various molecular characteristics, including the condition of the DNA, the gene expression as well as the protein expression in specific areas of the tissue, on the basis of the histological images.
Next on the agenda are certification and further clinical validations - including tests in tumor routine diagnostics. However, Frederick Klauschen is already convinced of the value of the research: “The methods we have developed will make it possible in the future to make histopathological tumor diagnostics more precise, more standardized and qualitatively better.”
- breast cancer
- cancer diagnostics
- artificial intelligence
- tumor diagnostics
A team led by researchers from Charité – Universitätsmedizin Berlin has succeeded in deciphering a fundamental process of molecular biology: the incorporation of selenocysteine – the ‘21st amino acid’ – into selenium-containing proteins known as selenoproteins. These protein constructions a ... more
In the journal Science, researchers from Charité – Universitätsmedizin Berlin and Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) present new findings on the immune response against the coronavirus SARS-CoV-2. Their study is based on investigations of antibodies elicited by infe ... more
Using a bioink made from alginate and human cells, researchers at the Technical University (TU) Berlin and other institutions have printed a three-dimensional model of a cancer metastasis in healthy tissue. They used a commercially available bio-printer for this purpose, so that the tumor m ... more
Electroencephalography (EEG), electrocardiography (ECG), electromyography (EMG) – all of these non-invasive medical diagnostic methods rely on an electrode to measure and record electrical signals or voltage fluctuations of muscle or nerve cells underneath the skin. Depending on the type of ... more
Scientists at Martin Luther University Halle-Wittenberg (MLU) and TU Berlin have published their findings in the journal "Cell Reports". They investigated a multi-enzyme complex that plays an essential role in metabolism and have discovered that it functions differently than previously thou ... more
Inflammatory bowel disease (IBD) is a complex condition that requires a lifetime of care and increases a person's cancer risk. But its origins are still a mystery. Now, a team of researchers have created a new culture model of the human intestine where living tissue from a patient biopsy ca ... more
At the Engineering in Medicine and Biology Conference (EMBC) in Buenos Aires (Argentina), imec and its project partners announce the launch of the European Seventh Framework Project MIRACLE. The MIRACLE project aims at developing an operational lab-on-chip for the isolation and detection of ... more
Scientist from a consortium of Norwegian marine and aquaculture institutions announced that they have generated the first ever draft sequence and assembly of the Atlantic cod genome. The results, presented at the GenoFisk meeting in Oslo, Norway, include a high-quality genome assembly and p ... more
- 1Miniaturized Lab-on-a-Chip for real-time Chemical Analysis of Liquids
- 2Organic thin-film sensors for light-source analysis and anti-counterfeiting applications
- 3A new era of early cancer detection with blood test may change cancer screening paradigms
- 4Beckman Coulter Life Sciences acquires Dublin biotech start-up
- 5Less risk, less costs: Portable spectroscopy devices could soon become real
- 6Mobile phone app accurately detects COVID-19 infection in people’s voices with the help of artificial intelligence
- 7Show me your brain scan and I'll tell you how old you really are
- 8Sensing pressure using paper
- 9The predictive power of blood: metabolomic profiling reveals risk of multiple diseases all at once
- 10Pharmacoscopy: Next-Generation Microscopy
- Revealing the Genome of the Common Ancestor of All Mammals
- Structure of wheat immune protein resolved
- Digital lab management: Fully connected
- The predictive power of blood: metabolomic profiling reveals risk of multiple diseases all at once
- Show me your brain scan and I'll tell you how old you really are